Disease Focus: Spinal Cord Injury
Human Embryonic Stem Cell-Derived Neural Stem Cells for Severe Spinal Cord Injury (SCI)
Translational Candidate H9 (WA09) embryonic stem cell-derived neural stem cells with a spinal cord identity (H9-NSCsc) Area of Impact Severe spinal cord injury Mechanism of Action Our candidate therapy for SCI uses human neural stem cells in a gel-like matrix containing growth factors. We aim to fill the injury site with replacement neural stem cells […]
The 2nd Annual Spinal Cord Injury Investor Symposium (“2nd SCIIS”)
1st Annual Spinal Cord Injury Investor Symposium (SCIIS)
Human Embryonic Stem Cell-Derived Neural Stem Cells for Severe Spinal Cord Injury (SCI)
Therapeutic Candidate or Device Human embryonic stem cell-derived neural stem cells. Indication Spinal cord injury Therapeutic Mechanism The proposed neural stem cell therapy will be transplanted into a spinal cord injury site, providing cell replacement and a new neuronal relay across the injury site in an effort to promote significant functional improvement. Unmet Medical Need […]
Spinal Cord Injury and Stem Cells: Jake Javier, Clinical Trial Participant
On June 9th, 2016, Jake Javier seriously injured his spinal cord in a freak accident after diving into a swimming pool just one day before he was due to graduate from San Ramon Valley high school in the San Francisco Bay Area. 28 days later, Jake became the latest member of a very select group. […]
CURED: Stem Cell Clinical Trial Stories
Clinical trials are risky and rely on brave pioneers who are willing to put their bodies on the line to test something never before tried in people. At its December 2016 meeting, the governing Board of California’s Stem Cell Agency (CIRM) met four courageous heroes who have participated in CIRM-funded clinical trials and in two […]
Spinal Cord Injury and a CIRM-Funded Stem Cell-Based Trial
Jane Lebkowski, Asterias Biotherapeutics‘ VP of R&D, spoke to CIRM’s governing Board about the company’s CIRM-funded clinical trial for spinal cord injury. Richard Lajara, the fourth participant in a previous trial, gives a patient’s perspective. Related Links: Blog about the seminar Spinal cord injury fact sheet
Spinal Cord Injury and Stem Cell-Based Trials: What’s the Latest?
In this Google Hangout, Jane Lebkowski, PhD, president of research and development at Asterias Biotherapeutics, and Kevin Whittlesey, PhD, a CIRM science officer discuss the latest progress in stem cell-based research for treatment of spinal cord injury. Asterias has a $14 million CIRM grant to support their embryonic stem cell-based clinical trial for spinal cord […]
World’s 1st Human Embryonic Stem Cell Trial for Spinal Cord Injury – Katie Sharify
Katie Sharify was one of five people with spinal cord injuries to participate in the world’s first clinical trial testing human embryonic stem cells. The Geron sponsored trial was supported by California’s Stem Cell Agency (CIRM). In this video Katie speaks about her clinical trial experience with a group of scientists who were meeting to […]
Roman Reed: What all patient advocates at the World Stem Cell Summit should know
Roman Reed spoke with CIRM at the World Stem Cell Summit about what he thinks patients advocates should know about stem cell research. He came to the meeting in Pasadena to talk about stem cell advocacy. Roman got a spinal cord injury in 1994 and is the namesake of the Roman Reed Spinal Cord Injury […]